These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 19935460

  • 21. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.
    Knight RJ, Kerman RH, Zela S, Podder H, Van Buren CT, Katz S, Kahan BD.
    Transplantation; 2003 Apr 27; 75(8):1301-6. PubMed ID: 12717220
    [Abstract] [Full Text] [Related]

  • 22. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
    Eason JD, Loss GE, Blazek J, Nair S, Mason AL.
    Liver Transpl; 2001 Aug 27; 7(8):693-7. PubMed ID: 11510013
    [Abstract] [Full Text] [Related]

  • 23. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
    Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L.
    Liver Transpl; 2004 Mar 27; 10(3):404-7. PubMed ID: 15004768
    [Abstract] [Full Text] [Related]

  • 24. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
    Khanmoradi K, Knorr JP, Feyssa EL, Parsikia A, Jawa P, Dinh DB, Campos S, Zaki RF, Ortiz JA.
    Exp Clin Transplant; 2013 Jun 27; 11(3):222-8. PubMed ID: 23432665
    [Abstract] [Full Text] [Related]

  • 25. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT, Tubbs RS, Shoja MM, Ghafari A, Noshad H, Ardalan MR.
    Transplant Proc; 2008 Jun 27; 40(1):137-9. PubMed ID: 18261569
    [Abstract] [Full Text] [Related]

  • 26. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May 27; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 27. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
    Lim WH, Chadban SJ, Campbell S, Dent H, Russ GR, McDonald SP.
    Nephrology (Carlton); 2010 Apr 27; 15(3):368-76. PubMed ID: 20470309
    [Abstract] [Full Text] [Related]

  • 28. Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety.
    Esposito L, Kamar N, Durand D, Rostaing L.
    Transplant Proc; 2005 Mar 27; 37(2):892-4. PubMed ID: 15848567
    [Abstract] [Full Text] [Related]

  • 29. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 30. BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes.
    Benavides CA, Pollard VB, Mauiyyedi S, Podder H, Knight R, Kahan BD.
    Transplantation; 2007 Jul 15; 84(1):83-8. PubMed ID: 17627242
    [Abstract] [Full Text] [Related]

  • 31. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D.
    J Nephrol; 2004 Jul 15; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [Abstract] [Full Text] [Related]

  • 32. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.
    Wang D, Wu WZ, Yang SL, Chen JH, Tan JM.
    Chin Med J (Engl); 2006 Oct 20; 119(20):1683-8. PubMed ID: 17097014
    [Abstract] [Full Text] [Related]

  • 33. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.
    Martins L, Fonseca I, Almeida M, Henriques AC, Dias L, Sarmento AM, Cabrita A.
    Transplant Proc; 2005 Oct 20; 37(6):2755-8. PubMed ID: 16182802
    [Abstract] [Full Text] [Related]

  • 34. Prophylactic cytolytic therapy in heart transplantation: monoclonal versus polyclonal antibody therapy.
    Laske A, Gallino A, Schneider J, Bauer EP, Carrel T, Pasic M, von Segesser LK, Turina MI.
    J Heart Lung Transplant; 1992 Oct 20; 11(3 Pt 1):557-63. PubMed ID: 1610864
    [Abstract] [Full Text] [Related]

  • 35. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A, Daniel V, Dengler TJ, Schnabel PA, Hagl S, Sack FU.
    J Heart Lung Transplant; 2005 Jun 20; 24(6):708-13. PubMed ID: 15949731
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients.
    Lim WH, Chang SH, Chadban SJ, Campbell SB, Dent H, Russ GR, McDonald SP.
    Transplantation; 2009 Nov 27; 88(10):1208-13. PubMed ID: 19935375
    [Abstract] [Full Text] [Related]

  • 37. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D.
    Transplantation; 2008 Apr 15; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [Abstract] [Full Text] [Related]

  • 38. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE, Weng RR, Piper M, Laugenou K, Ichii H, Lakey J, Malinoski D.
    Transplant Proc; 2012 Jan 15; 44(1):164-6. PubMed ID: 22310605
    [Abstract] [Full Text] [Related]

  • 39. Comparison of cyclosporine and tacrolimus in combination with rabbit antithymocyte immunoglobulins as induction therapy in cardiac transplantation.
    Jacques F, Carrier M, Pelletier GB, Racine N, White M, Perrault LP, Pellerin M.
    Transplant Proc; 2009 Oct 15; 41(8):3337-41. PubMed ID: 19857745
    [Abstract] [Full Text] [Related]

  • 40. Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients.
    Hardinger KL, Brennan DC, Schnitzler MA.
    Transplantation; 2009 May 15; 87(9):1372-6. PubMed ID: 19424038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.